Flow cytometry in bioanalysis – precision, partnership and the power of innovation

Flow cytometry continues to evolve as a cornerstone technology in bioanalysis, driven by rapid advancements in instrumentation and data analytics. The integration of high-parameter and spectral platforms with intelligent data processing tools is transforming how cell-based biomarker data is captured from precious clinical samples. These innovations are redefining assay development, validation and deployment across global clinical trials in pharmaceutical, biotech and clinical research organizations (CROs).

This Spotlight convenes leading experts to examine the expanding role of flow cytometry in clinical research and the critical importance of strategic partnerships in enabling successful trial execution. Through harmonized workflows and the strategic application of cutting-edge technologies, collaboration fosters efficiency and creates enhanced scientific value.

Furthermore, the Spotlight addresses challenges and emerging opportunities in bioanalytical flow cytometry, including rare event detection, minimal residual B-cell monitoring, robust instrument standardization and harmonization across global sites. It also explores the potential of algorithms and machine learning to revolutionize data processing and drive enhanced analytical precision and data quality.

By emphasizing innovation, standardization and real-world applications, this series showcases the drivers shaping the future of bioanalytical flow cytometry in clinical development.

This feature was produced in association with: